Kidney Cancer  >>  ispinesib (SB-715992)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ispinesib (SB-715992) / Cytokinetics
NCT00354250: Ispinesib in Treating Patients With Metastatic or Unresectable Kidney Cancer

Completed
2
60
US
ispinesib, CK0238273, SB-715992
National Cancer Institute (NCI)
Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
02/07
 

Download Options